NCT04838912

Brief Summary

The objective is to investigate the feasibility of a newly developed manualised group Cognitive Behavioural Therapy (CBT) programme for anxiety in 15 teenagers (aged 13-17 years) with Autism Spectrum Disorder (ASD). Our aim is to focus primarily on acceptability and compliance with the program with some investigation of treatment effects on anxiety diagnosis and anxiety symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2023

Completed
Last Updated

July 6, 2023

Status Verified

November 1, 2022

Enrollment Period

2.1 years

First QC Date

March 25, 2021

Last Update Submit

July 4, 2023

Conditions

Keywords

CBTAnxietyAutismFeasibilityTeenagers

Outcome Measures

Primary Outcomes (1)

  • The Experience of Service Questionnaire

    A questionnaire measuring teenagers and parents satisfaction with the treatment. On a Likert scale they will be asked to rate positive statements as 'not true' (1), 'partly true' (2), or 'true' (3) and in an open section freely comment on their experience with the treatment.

    Interview at 14 weeks after start of treatment

Secondary Outcomes (8)

  • Anxiety Disorders Interview Schedule for DSM-IV: Parent & Child interview schedule (ADIS C/P)

    Change from baseline interview results at 14 weeks

  • Anxiety Disorders Interview Schedule for DSM-IV: Parent & Child interview schedule (ADIS C/P)

    Change from baseline interview results at 3 months

  • Spence Children's Anxiety Scale (SCAS)

    Change from baseline results at 14 weeks

  • Spence Children's Anxiety Scale (SCAS)

    Change from baseline results at 3 months

  • Children's Anxiety Life Inference Scale (CALIS)

    Change from baseline results at 14 weeks

  • +3 more secondary outcomes

Study Arms (1)

Cool Kids ASA

EXPERIMENTAL

The Cool Kids (Chilled) ASA anxiety program

Behavioral: Cool Kids (Chilled) Anxiety program adapted to children and youths with autism and anxiety disorders.

Interventions

CBT program for anxiety in teenagers with autism

Cool Kids ASA

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Fulfil the diagnostic criteria for one or more anxiety diagnoses on the Anxiety Disorders Interview Schedule for DSM-IV: Parent \& Child interview schedule (ADIS C/P)
  • Obtained a diagnosis of ASD according to the International Classification of Diseases, 10th edition (ICD 10)

You may not qualify if:

  • low intellectual functioning (\<70)
  • active psychosis
  • untreated hyperkinetic disorder
  • inability to speak Danish
  • inability to leave the home
  • inability to attend a group setting
  • inability to meet for treatment caused by other psychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Auhus University Hospital, Psychiatry

Aarhus N, 8200, Denmark

Location

MeSH Terms

Conditions

Anxiety DisordersAutistic Disorder

Condition Hierarchy (Ancestors)

Mental DisordersAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Fifteen teenagers aged 13-17 years with an active ASD diagnosis and experiencing life interference anxiety symptoms will be divided into 3 groups and treated with the Cool Kids AST anxiety program
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2021

First Posted

April 9, 2021

Study Start

June 1, 2021

Primary Completion

July 4, 2023

Study Completion

July 4, 2023

Last Updated

July 6, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Individual data will not be shared. Only overall data on the group will be shared due to the Danish Data Protection Act.

Locations